However, a current lack of funding and political impetus mean coverage of interventions is suboptimal, and elimination targets are unlikely to be met. We aim to use mathematical models to help provide evidence-based solutions to overcome these barriers, including:
- Health and economic benefits of expanding intervention coverage across a range of national and international settings
- Value propositions for alternate or new technologies to assist in achieving hepatitis B elimination targets
- An OPTIMA HBV model to improve allocative efficiency of interventions within countries.
2018 – ongoing
Project
Team
Meet the project team. Together, we are translating research into better health, for all.
